top of page
About us
Peripal AG is a privately funded start-up from the ETH Zürich and the MedTech industry. The team offers a unique combination of product development capabilities, a longstanding experience in the dialysis market, a successful track record of strategy, sales and marketing positions, and an excellent network in the nephrology community.
Vision:
Allow patients to be treated at home and reduce healthcare costs.
Founder, Dr. Sandra Neumann about PeriSafe®

Peripal - Preisträger W.A. de Vigier 2016
Play Video